Rhythm Pharmaceuticals Inc at Bank of America Merrill Lynch Health Care Conference Transcript
I'm Brian Cheng. I'm the Senior Associate on (inaudible) SMID cap biotech team here at Bank of America. It's a pleasure to introduce our next speaker, the CEO of Rhythm Pharmaceuticals, Keith Gottesdiener. And we also have the CFO, Hunter Smith, here in the audience as well. Welcome, today.
Thank you. Hello.
So maybe to get us started, let's kind of give us an overview of where you are in terms of your clinical development in the genetic obesity, and then we'll dive deeper into each of the genetic indications.
Sure. I'll be happy to actually. I actually have mic'd up so it's not necessary. So Rhythm's focused on rare genetic cause of obesity. We've
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
